Search

everythinglearnresearchcommunity

for

Search:↓

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Visual field defects in lupus nephritis can be caused by hypertensive retinopathy, not glaucoma or medication toxicity.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

Women's hair gets thinner and grayer as they age, with treatments available for hair loss and graying.

Androgens can cause acne, excess hair, and hair loss, treatable with dermatologist-guided therapies.

Pregnancy can cause skin changes and conditions that need correct diagnosis and treatment for the health of the mother and baby.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

The document concludes that treatments like oral anti-androgens, minoxidil, and topical spironolactone can be effective for hair loss in men and women.

The symposium concluded that hair growth involves complex processes, including the hair follicle life cycle, the role of the dermal papilla, hair strength, pigmentation, and the impact of diseases and treatments like minoxidil on hair and skin.

A new microneedle system effectively delivers finasteride to treat hair loss.

Early detection and treatment of primary biliary cirrhosis and related autoimmune diseases improve outcomes.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

New acne treatments show promise as alternatives to traditional therapies.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

A man with Acrodermatitis continua did not get better with etanercept treatment, and his condition worsened, suggesting treatment effectiveness may vary by genetics and race.

The index to ring finger ratio may indicate disease severity in female ankylosing spondylitis patients, but not in males.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

Andrographolide-loaded topical nanocarriers are a safe and effective treatment for psoriasis.

The article suggests that five common skin-related lab tests may be unnecessary and could cause extra cost and anxiety without improving patient care.

IL-12/23 inhibitors are more effective and have fewer common side effects than anti-TNF alpha for treating psoriasis.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

New therapies for rare skin diseases show promise but need more research.

Transforming skin disease treatment requires new strategies, better drug models, and patient-focused research.

Androgenetic alopecia treatments are becoming more personalized and include new therapies like topical antiandrogens and regenerative strategies.

Combining hydroxychloroquine and pimecrolimus can effectively treat hair loss from discoid lupus.

More research is needed to find the best long-term treatments for Alopecia Areata.

Secukinumab can cause hair loss, which may improve after stopping the medication.